Erratum (Retracted article): Association of angiotensin converting enzyme gene polymorphisms with left ventricular hypertrophy (Hypertension Research (2008) vol. 28 (345-349) 10.1291/hypres.28.345);Association of angiotensin converting enzyme gene polymorphisms with left ventricular hypertrophy

Hypertension Research

Volumn 28, Issue 4, 2005, Pages 345-349

  Saeed, Mohammad ^a   Saleheen, Danish ^a   Siddiqui, Sammer ^a   Khan, Aisha ^a   Butt, Zahid A ^a   Frossard, Philippe M ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

Angiotensin coverting enzyme; Genetics; Left ventricular hypertrophy; Polymorphisms

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MALE; QUANTITATIVE TRAIT LOCUS; RETROSPECTIVE STUDY; UNITED ARAB EMIRATES;

EID: 21244486697     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2009.54     Document Type: Erratum

References (28)

1. Cambien F, Poirier O, Lecerf L, et al: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-644.
2. Ganau A, Devereux RB, Pickering TG, et al: Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. Circulation 1990; 81: 25-36.
3. Savage DD, Levy D, Dannenberg AL, Garrison RJ, Castelli WP: Association of echocardiographic left ventricular mass with body size, blood pressure, and physical activity (the Framingham Study). Am J Cardiol 1990; 65: 371-376.
4. Drayer JIM, Weber MA, DeYoung JL: BP as a determinant of cardiac left ventricular muscle mass. Arch Intern Med 1983; 143: 90-92.
5. van Berlo, JH, Pinto YM: Polymorphisms in the RAS and cardiac function. Int J Biochem Cell Biol 2003; 35: 932-943.
6. Dzau VJ: Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch Intern Med 1993; 153: 937-942.
7. Iwashima Y, Horio T, Kuroda S, Takishita S, Kawano Y: Influence of plasma aldosterone on left ventricular geometry and diastolic function in treated essential hypertension. Hypertens Res 2002; 25: 49-56.
8. Matsuzaki K, Mukai M, Sumimoto T, Murakami E: Effects of ACE inhibitors versus calcium antagonists on left ventricular morphology and function in patients with essential hypertension. Hypertens Res 1997; 20: 7-10.
9. Miller JA, Scholey JW: The impact of renin-angiotensin system polymorphisms on physiological and pathophysiological processes in humans. Curr Opin Nephrol Hypertens 2004; 13: 101-106.
10. Dang A, Zheng D, Wang B, et al: The role of the reninangiotensin and cardiac sympathetic nervous systems in the development of hypertension and left ventricular hypertrophy in spontaneously hypertensive rats. Hypertens Res 1999; 22: 217-221.
11. Matsubara M, Metoki H, et al: T+31C polymorphism (M235T) of the angiotensinogen gene and home blood pressure in the Japanese general population: the Ohasama Study. Hypertens Res 2003; 26: 47-52.
12. Ono K, Mannami T, Baba S, Yasui N, Ogihara T, Iwai N: Lack of association between angiotensin II type 1 receptor gene polymorphism and hypertension in Japanese. Hypertens Res 2003; 26: 131-134.
13. Gesang L, Liu G, Cen W, et al: Angiotensin-converting enzyme gene polymorphism and its association with essential hypertension in a Tibetan population. Hypertens Res 2002; 25: 481-485.
14. Tamaki S, Nakamura Y, Tsujita Y, et al: Polymorphism of the angiotensin converting enzyme gene and blood pressure in a Japanese general population (the Shigaraki Study). Hypertens Res 2002; 25: 843-848.
15. Zhu X, Bouzekri N, Southam L, et al: Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet 2001; 68: 1139-1148.
16. Lindpaintner K, Lee M, Larson MG, et al: Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med 1996; 334: 1023-1028.
17. Schunkert H, Hense HW, Holmer SR, et al: Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994; 330: 1634-1638.
18. Saeed Mahmood M, Saboohi K, Osman Ali S, Bokhari AM, Frossard PM: Association of the angiotensin-converting enzyme (ACE) gene G2350A dimorphism with essential hypertension. J Hum Hypertens 2003; 17: 719-723.
19. Obineche EN, Frossard PM, Bokhari AM: An association study of five genetic loci and left ventricular hypertrophy amongst Gulf Arabs. Hypertens Res 2001; 24: 635-639.
20. Sokolow M, Lyon TP: The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949; 37: 161-186.
21. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning, a Laboratory Manual, 2nd ed. New York, Cold Spring Harbour Laboratory Press, 1989.
22. Haviland MB, Kessling AM, Davignon J, Sing CF: Estimation of Hardy-Weinberg pairwise disequilibrium in apolipoprotein AI-CIII-AIV gene cluster. Am J Hum Genet 1991; 49: 350-365.
23. Thompson EA, Deeb S, Walker D, Motulsky AG: The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes. Am J Hum Genet 1988; 42: 113-124.
24. Zhao JH, Curtis D, Sham PC: Model-free analysis and permutation tests for allelic associations. Hum Hered 2000; 50: 133-139.
25. Kuznetsova T, Staessen JA, Stolarz K, et al: European Project On Genes in Hypertension (EPOGH) Investigators. Relationship between left ventricular mass and the ACE D/I polymorphism varies according to sodium intake. J Hypertens 2004; 22: 287-295.
26. Shlyakhto EV, Shwartz EI, Nefedova YB, Zukova AV, Vinnic TA, Conrady AO: Lack of association of the renin-angiotensin system genes polymorphisms and left ventricular hypertrophy in hypertension. Blood Press 2001; 10: 135-141.
27. Wu S, Hong J, Li H, et al: No correlation of polymorphism of angiotensin-converting enzyme genes with left ventricular hypertrophy in essential hypertension. Hypertens Res 2000; 23: 261-264.
28. Mathew J, Sleight P, Lonn E, Johnstone D: Heart Outcomes Prevention Evaluation (HOPE) Investigators. Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation 2001; 104: 1615-1621.